Blagden, S P, Billingham, L, Brown, L C, Buckland, S W, Cooper, A M, Ellis, S, Fisher, W, Hughes, H, Keatley, D A, Maignen, F M, Morozov, A, Navaie, W, Pearson, S, Shaaban, A, Wydenbach, K, Kearns, P R, Abouzeid, C, Ahmed, R, Bailey, S, Blewett, C, Campbell, H, Cerone, M A, Clack, G, Cook, N, Ghiorghiu, S, Halford, S, Johnston, A, Kaplan, R, Lawson, A, Lowe, E, Mathews, J, Mirabile, I, Osipenko, L, Patel, D, Potter, C, Regan, A, Ricamara, M, Ringrose, C, Rodger, J, Sandhu, G K, Schiavone, F, Silvester, J, Sydes, M R, Weller, C & Yiangou, A 2020, ' Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement ', British Journal of Cancer, vol. 122, no. 4, pp. 473-482 . https://doi.org/10.1038/s41416-019-0653-9 British Journal of Cancer
Shaw, R H, Liu, X, Stuart, A S V, Greenland, M, Aley, P K, Andrews, N J, Finn, A & Lazarus, R & et, A 2022, ' Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules : exploratory analyses of Com-COV, a randomised control trial ', Lancet Respiratory Medicine, vol. 10, no. 11, pp. 1049-1060 . https://doi.org/10.1016/S2213-2600(22)00163-1